Founder and CEO
PhD;Nanyang Technological University,Singapore
ABOUT
US
US
COMPANY OVERVIEW
Spectrumedics is an innovative medical device start-up delivering disruptive technologies to
address unmet clinical needs in the treatment of cardiovascular diseases.
The company was founded by the scientist-engineer duo who possess more than 10 years of
industrial experience in the development and manufacturing of minimally invasive cardiovascular
devices.
Spectrumedics is highly dedicated to product innovation.We focus on the integration of energy-based technologies with interventional
techniques.
Spectrumedics has developed a platform technology that supports broad clinical applications to
overcome the various challenges of cardiovascular calcification.
The first application of the Sonico Intravascular Lithotripsy would be in the
treatment of stenotic calcified lesions in the coronary arteries.
CORPORATE
VALUES
MISSION
Driven by cutting-edge technology
we aim to revolutionize medical innovation
and enhance qualiy of life.
we aim to revolutionize medical innovation
and enhance qualiy of life.
VISION
To be a medical innovator with
an international perspective.
an international perspective.
TARGET
Our goal is to establish ourselves
as a pioneering medical device company,
recognized for out leadership in active
intervention treatments for cardiovascular
and peripheral vascular conditions.
as a pioneering medical device company,
recognized for out leadership in active
intervention treatments for cardiovascular
and peripheral vascular conditions.
OUR TEAM
Elynn PHANG,PhD
10+ years of R&D,clinical research and business development experience in asset
spin-offs,
IP licensing and early - stage financing
Previously led transcatheter heart value portfolio for a highly innovative,patent - protected technology and led multiple financing rounds for the company
Led clinical research division at MERCI, a Singapore - based MedTech in-cubator and prior to that led clinical and product development for a novel Drug Coated Balloon(DCB) technology
Affiliated Research Group of Professor Sydney Brenner,Nobel Proze winner
Previously led transcatheter heart value portfolio for a highly innovative,patent - protected technology and led multiple financing rounds for the company
Led clinical research division at MERCI, a Singapore - based MedTech in-cubator and prior to that led clinical and product development for a novel Drug Coated Balloon(DCB) technology
Affiliated Research Group of Professor Sydney Brenner,Nobel Proze winner
Al Ray Tabiliran
Co-Founder
BS, Engineering, University of San Jose - Recoletos
BS, Engineering, University of San Jose - Recoletos
10+ years of R&D and manufacturing experience and leading MedTech companies such as
Forefront Medical, Creganna – Tactx Medical and TriReme Medical
Deep product development expertise in catheter – based technologies such as angioplasty balloons for coronary and peripheral artery diseases
BS, Engineering, University of San Jose - Recoletos
Deep product development expertise in catheter – based technologies such as angioplasty balloons for coronary and peripheral artery diseases
BS, Engineering, University of San Jose - Recoletos
SPECTRUMEDICS
Shanghai
China
GMP Production
20000
Cleanroom
ISO-7
Singapore
R&D Lab
5382
Professionals
100
